Selection at a γ-aminobutyric acid receptor gene in Haemonchus contortus resistant to avermectins/milbemycins

被引:55
作者
Blackhall, WJ [1 ]
Prichard, RK [1 ]
Beech, RN [1 ]
机构
[1] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ H9X 3V4, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
Haemonchus contortus; avermectin; moxidectin; GABA receptor; drug resistance;
D O I
10.1016/S0166-6851(03)00201-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
g-aminobutyric acid (GABA) Type A receptors are inhibitory chloride channels in membranes of vertebrate and invertebrate neuromuscular cells. Gating of the channels by GABA leads to an influx of chloride ions into, and hyperpolarisation of, the cell. GABA receptors are believed to form channels by the association of five protein molecules of varying subunit types, with the second transmembrane (M2) domain of each protein molecule forming a central pore through which chloride ions can pass. We have analysed by single-strand conformation polymorphism the genetic variation of a GABA-receptor gene, HG1, from two sets of unselected and anthelmintic-selected strains of the parasitic nematode Haemonchus contortus. Significant differences in allele frequencies were detected between one unselected strain and its derived ivermectin-selected strain and between the other unselected strain and its derived ivermectin- and moxidectin-selected strains. In each set of strains, one allele increased substantially in frequency in the drug-selected strains relative to their respective unselected strains. The selected allele, however, differed between the two sets of strains. Similar analyses were performed on a phosphoenolpyruvate carboxykinase gene and a nicotinic acetylcholine receptor subunit gene. No significant differences were found in allele frequencies between the unselected and their derived anthelmintic-selected strains. These results indicate the GABA receptor as a possible site of action for avermectins and milbemycins, and suggest its involvement in resistance to these anthelmintics. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:137 / 145
页数:9
相关论文
共 60 条
[1]   THE MECHANISM OF ACTION OF AVERMECTINS IN CAENORHABDITIS-ELEGANS - CORRELATION BETWEEN ACTIVATION OF GLUTAMATE-SENSITIVE CHLORIDE CURRENT, MEMBRANE-BINDING, AND BIOLOGICAL-ACTIVITY [J].
ARENA, JP ;
LIU, KK ;
PARESS, PS ;
FRAZIER, EG ;
CULLY, DF ;
MROZIK, H ;
SCHAEFFER, JM .
JOURNAL OF PARASITOLOGY, 1995, 81 (02) :286-294
[2]   EXPRESSION OF A GLUTAMATE-ACTIVATED CHLORIDE CURRENT IN XENOPUS-OOCYTES INJECTED WITH CAENORHABDITIS-ELEGANS RNA - EVIDENCE FOR MODULATION BY AVERMECTIN [J].
ARENA, JP ;
LIU, KK ;
PARESS, PS ;
SCHAEFFER, JM ;
CULLY, DF .
MOLECULAR BRAIN RESEARCH, 1992, 15 (3-4) :339-348
[3]   EFFECTS OF STARVATION AND NEUROACTIVE DRUGS ON FEEDING IN CAENORHABDITIS-ELEGANS [J].
AVERY, L ;
HORVITZ, HR .
JOURNAL OF EXPERIMENTAL ZOOLOGY, 1990, 253 (03) :263-270
[4]  
Bamber BA, 1999, J NEUROSCI, V19, P5348
[5]   Neurobiology of the Caenorhabditis elegans genome [J].
Bargmann, CI .
SCIENCE, 1998, 282 (5396) :2028-2033
[6]  
BEECH RN, 1994, GENETICS, V138, P103
[7]   MUTATIONS AT 2 DISTINCT SITES WITHIN THE CHANNEL DOMAIN M2 ALTER CALCIUM PERMEABILITY OF NEURONAL ALPHA-7 NICOTINIC RECEPTOR [J].
BERTRAND, D ;
GALZI, JL ;
DEVILLERSTHIERY, A ;
BERTRAND, S ;
CHANGEUX, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (15) :6971-6975
[8]   Haemonchus contortus:: Selection at a glutamate-gated chloride channel gene in ivermectin- and moxidectin-selected strains [J].
Blackhall, WJ ;
Pouliot, JF ;
Prichard, RK ;
Beech, RN .
EXPERIMENTAL PARASITOLOGY, 1998, 90 (01) :42-48
[9]   Selection at a P-glycoprotein gene in ivermectin- and moxidectin-selected strains of Haemonchus contortus [J].
Blackhall, WJ ;
Liu, HY ;
Xu, M ;
Prichard, RK ;
Beech, RN .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1998, 95 (02) :193-201
[10]   TOXICOLOGY, MODE OF ACTION AND TARGET SITE-MEDIATED RESISTANCE TO INSECTICIDES ACTING ON CHLORIDE CHANNELS [J].
BLOOMQUIST, JR .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY, 1993, 106 (02) :301-314